Australia's largest stock trading and investment forum Australia's #1 stock forum

HMD

Click for more information

0.00%

1.8¢ heramed limited

Yes, the ease of use was subjective. And yes, these results...

First 20 Last

Share
Profile

Follow
greatwuggawugga

263 Posts.

24

19/09/23

22:52

Post #: 69924543
Share

Originally posted by Backspacer: ↑

From memory the mayo trial used subjective measures of accuracy compared to the JHC trial which compared current standard to the Herabeat at the heart race trace level.

the result of the usability scale were both subjective so that was a disappointing finding. However I wonder if the score would be higher if the full benefit/integration of the platform was considered. Its not quite apple to apples if the standard doppler cant integrate with a broader platform which as we have long been saying is the main play here; the doppler being somewhat of a side show.

When i read the result some time back i didnt think the mayo trial wasnt particularly well thought out and designed. In regards to management being quiet, maybe they feel the same and wouldnt come out and say as such.

Expand

Yes, the ease of use was subjective. And yes, these results might mean little considering the larger picture of integration etc. Let’s hope, anyway.

HMD Price at posting: 6.3¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 14 more messages in this thread...

First 20 Last

Add HMD (ASX) to my watchlist

SPONSORED BY